EvidenceHunt, an Amsterdam, the Netherlands-based supplier of an AI-powered medical analysis platform, raised €1.2M in funding.
The spherical was led by Eager Enterprise Companions, Dff.ventures and Slimmer AI with participation from angel traders, together with Jeroen Tas (former Chief Technique and Innovation Officer at Philips), Dinko Valerio (former CEO and Founder Crucell), and James Shannon (former Head of International Drug Growth Novartis).
The corporate intends to make use of the funds to increase its capabilities, enabling groups and organizations to course of medical info.
Led by CEO Philippe Habets, EvidenceHunt supplies an AI-powered medical analysis platform that enables professionals to pinpoint, analyze, and make the most of proof. Customers can ask questions and obtain clear, summarized solutions inside seconds, full with cited sources and trackable particulars for immediate verification of how the AI has generated its solutions.
EvidenceHunt launched its platform 18 months in the past following two years of analysis and scientific validation of its core elements. Since then, it has grown organically to a worldwide userbase of 25,000 energetic and returning customers, together with healthcare professionals, medical science specialists, researchers and college students throughout 90+ international locations.
As we speak, the corporate serves a worldwide consumer base throughout numerous sectors, together with pharmaceutical and medical machine corporations, healthcare suppliers and educational establishments.
FinSMEs
27/02/2025
